Using the GS for total testosterone and SHBG and the hypogonadism genetic risk score (GRS) that we developed from our GWAS analyses, we identified associations between testosterone gene variants and the risk of certain diseases, especially metabolic diseases such as diabetes, gout, and hyperlipidemia. This evidence concerns the gene SHBG and hypogonadism.